Screener
Charles River Laboratories CRL Other — Total Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Service revenue | $808,287 | $840,836 | $1,606,439 | $1,638,759 |
| Product revenue | 195,791 | 191,299 | 393,469 | 377,544 |
| Total revenue | 1,004,078 | 1,032,135 | 1,999,908 | 2,016,303 |
| Costs and expenses | ||||
| Cost of services provided (excluding amortization of intangible assets) | 552,007 | 584,876 | 1,160,914 | 1,162,304 |
| Cost of products sold (excluding amortization of intangible assets) | 88,697 | 90,192 | 180,956 | 179,200 |
| Selling, general and administrative | 228,897 | 191,549 | 388,319 | 369,348 |
| Amortization of intangible assets | 14,589 | 65,384 | 29,934 | 130,648 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's other — total revenue?
- Charles River Laboratories (CRL) reported other — total revenue of $13.12M in Q2 2026.
- How has Charles River Laboratories's other — total revenue changed year-over-year?
- Charles River Laboratories's other — total revenue increased by 27.0% year-over-year, from $10.33M to $13.12M.
- What is the long-term trend for Charles River Laboratories's other — total revenue?
- Over 4 years (2021 to 2025), Charles River Laboratories's other — total revenue has grown at a 72.7% compound annual growth rate (CAGR), from $7.29M to $64.87M.
- What does other — total revenue mean?
- This metric represents the total revenue generated by business activities or geographic regions that do not meet the quantitative thresholds for separate reporting as a primary operating segment. It captures the aggregate financial contribution from miscellaneous, emerging, or non-core business units within the organization. Monitoring this figure helps investors understand the scale of ancillary operations and the potential for these units to grow into significant revenue drivers.
Ask your AI about Charles River Laboratories's other — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude